# Trinity Capital Inc.: overview TRIN · NYSE · CIK 1786108 · [Other](/sectors/other.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/trin.md) · [Financials](/companies/trin/financials.md) · [Filings](/companies/trin/filings.md) · [Insiders](/companies/trin/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.43](/filings/0001193125-25-265807.md) | not reported | [0.43](/filings/0001193125-26-207620.md) | [0.63](/filings/0001193125-26-333907.md) | [0.39](/filings/0001193125-25-265807.md) | not reported | [0.36](/filings/0001193125-26-207620.md) | [0.49](/filings/0001193125-26-333907.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [4.64](/filings/0000950170-24-026865.md) | [(0.96)](/filings/0000950170-25-027341.md) | [1.89](/filings/0001193125-26-068600.md) | [2.10](/filings/0001193125-26-068600.md) | [1.96](/filings/0001193125-26-068600.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/trin/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [VAN ECK ASSOCIATES CORP](/funds/869178.md) | 2026-06-30 | $38.5m | 2,153,437 | | Added +607,988 | | [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $33.0m | 1,844,897 | | Added +1,285,450 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $26.7m | 1,490,148 | | Added +451,078 | | [Melia Wealth LLC](/funds/1964047.md) | 2026-06-30 | $24.2m | 1,353,898 | | Added +56,526 | | [Sound Income Strategies, LLC](/funds/1730960.md) | 2026-06-30 | $22.7m | 1,269,744 | | Added +109,291 | | [Union Bancaire Privee, UBP SA](/funds/1716607.md) | 2026-06-30 | $16.5m | 5,973 | | Unchanged | | [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $15.1m | 844,773 | | New +844,773 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $13.7m | 764,296 | | Added +231,450 | | [FRANKLIN RESOURCES INC](/funds/38777.md) | 2026-06-30 | $13.4m | 749,576 | | Added +8,766 | | [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $13.4m | 746,720 | | Reduced −204,761 | ## Recent filings [All 565 filings](/companies/trin/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-08 | 21:30 ET | [8-K](/filings/0001193125-26-418097.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-418097 | | 2026-10-05 | 20:52 ET | [8-K](/filings/0001213900-26-106862.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-26-106862 | | 2026-08-05 | 12:04 ET | [10-Q](/filings/0001193125-26-333907.md) | Quarterly report, period 2026-06-30 | 0001193125-26-333907 | | 2026-08-05 | 12:00 ET | [8-K](/filings/0001193125-26-333904.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-333904 | | 2026-07-14 | 20:30 ET | [8-K](/filings/0001193125-26-303247.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-303247 | | 2026-07-09 | 20:30 ET | [8-K](/filings/0001193125-26-299742.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-299742 | | 2026-06-12 | 20:30 ET | [8-K](/filings/0001193125-26-269551.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-269551 | | 2026-05-21 | 20:20 ET | [8-K](/filings/0001213900-26-060069.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-26-060069 | | 2026-05-07 | 20:39 ET | [8-K](/filings/0001213900-26-053385.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-053385 | | 2026-05-06 | 12:02 ET | [10-Q](/filings/0001193125-26-207620.md) | Quarterly report, period 2026-03-31 | 0001193125-26-207620 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-068600.md), filed Feb 25, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1786108 - Tickers: TRIN, TRNI, TRNZ - Exchange: NYSE - SIC code: not reported - State of incorporation: MD - Filer category: Large accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.